Addus HomeCare (NASDAQ:ADUS) Upgraded at Truist Financial

Truist Financial upgraded shares of Addus HomeCare (NASDAQ:ADUSFree Report) to a strong-buy rating in a research note issued to investors on Wednesday morning,Zacks.com reports.

Several other equities analysts also recently commented on ADUS. Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. Barclays boosted their target price on shares of Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research note on Tuesday, November 4th. BMO Capital Markets assumed coverage on shares of Addus HomeCare in a research note on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price target on the stock. Royal Bank Of Canada boosted their price objective on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus target price of $136.90.

Get Our Latest Stock Report on ADUS

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS opened at $109.72 on Wednesday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.14. Addus HomeCare has a 12 month low of $88.96 and a 12 month high of $136.72. The company has a market capitalization of $2.03 billion, a price-to-earnings ratio of 23.49, a PEG ratio of 1.35 and a beta of 0.92. The firm’s 50-day moving average is $113.11 and its 200 day moving average is $113.42.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its quarterly earnings data on Monday, November 3rd. The company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.53 by $0.03. The business had revenue of $362.30 million during the quarter, compared to the consensus estimate of $354.48 million. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. The firm’s quarterly revenue was up 25.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.30 earnings per share. Research analysts predict that Addus HomeCare will post 4.59 EPS for the current year.

Insider Buying and Selling

In related news, EVP Darby Anderson sold 20,000 shares of the stock in a transaction that occurred on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total value of $2,180,000.00. Following the transaction, the executive vice president owned 44,144 shares in the company, valued at approximately $4,811,696. This represents a 31.18% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold a total of 20,316 shares of company stock valued at $2,215,998 in the last 90 days. 4.50% of the stock is owned by corporate insiders.

Institutional Trading of Addus HomeCare

Several large investors have recently made changes to their positions in ADUS. Tributary Capital Management LLC raised its holdings in shares of Addus HomeCare by 114.1% during the third quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock worth $46,974,000 after purchasing an additional 212,192 shares during the last quarter. Capital Research Global Investors raised its stake in shares of Addus HomeCare by 9.0% during the 3rd quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock valued at $141,772,000 after buying an additional 99,262 shares during the last quarter. Leeward Investments LLC MA acquired a new position in shares of Addus HomeCare in the 2nd quarter valued at about $9,152,000. 8 Knots Management LLC purchased a new stake in shares of Addus HomeCare in the third quarter worth about $6,075,000. Finally, TimesSquare Capital Management LLC grew its holdings in Addus HomeCare by 13.9% during the second quarter. TimesSquare Capital Management LLC now owns 394,047 shares of the company’s stock worth $45,390,000 after acquiring an additional 48,207 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

About Addus HomeCare

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Featured Articles

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.